• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid.硼酸盐对 HIV-1 蛋白酶的亚皮摩尔抑制作用。
J Am Chem Soc. 2018 Oct 31;140(43):14015-14018. doi: 10.1021/jacs.8b07366. Epub 2018 Oct 22.
2
Potent HIV-1 Protease Inhibitors Containing Carboxylic and Boronic Acids: Effect on Enzyme Inhibition and Antiviral Activity and Protein-Ligand X-ray Structural Studies.含羧酸和硼酸的强效HIV-1蛋白酶抑制剂:对酶抑制和抗病毒活性的影响以及蛋白质-配体X射线结构研究
ChemMedChem. 2019 Nov 6;14(21):1863-1872. doi: 10.1002/cmdc.201900508. Epub 2019 Oct 4.
3
Inhibition of HIV-1 Protease by a Boronic Acid with High Oxidative Stability.具有高氧化稳定性的硼酸对HIV-1蛋白酶的抑制作用。
ACS Med Chem Lett. 2023 Jan 25;14(2):171-175. doi: 10.1021/acsmedchemlett.2c00464. eCollection 2023 Feb 9.
4
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.包含立体定义的 P2' 配体以优化底物信封中氢键的 HIV-1 蛋白酶抑制剂。
J Med Chem. 2019 Sep 12;62(17):8062-8079. doi: 10.1021/acs.jmedchem.9b00838. Epub 2019 Aug 21.
5
Structural Basis of Why Nelfinavir-Resistant D30N Mutant of HIV-1 Protease Remains Susceptible to Saquinavir.HIV-1蛋白酶的奈非那韦耐药性D30N突变体对沙奎那韦仍敏感的结构基础。
Chem Biol Drug Des. 2015 Sep;86(3):302-8. doi: 10.1111/cbdd.12494. Epub 2015 Jan 9.
6
Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.设计并合成具有新型异山梨醇衍生 P2 配体的高效抗 HIV-1 蛋白酶抑制剂。
Bioorg Med Chem Lett. 2014 Jun 1;24(11):2465-8. doi: 10.1016/j.bmcl.2014.04.008. Epub 2014 Apr 13.
7
Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands.以叔胺作为P2配体的新型HIV-1蛋白酶抑制剂的合成及生物学评价
Bioorg Med Chem Lett. 2015 May 1;25(9):1880-3. doi: 10.1016/j.bmcl.2015.03.047. Epub 2015 Mar 24.
8
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.HIV-1蛋白酶抑制剂的耐药性耐受性:地瑞那韦概述
AIDS Rev. 2008 Jul-Sep;10(3):131-42.
9
Thermodynamic and structural analysis of HIV protease resistance to darunavir - analysis of heavily mutated patient-derived HIV-1 proteases.HIV 蛋白酶耐药性对达芦那韦的热力学和结构分析 - 对高度突变的患者源性 HIV-1 蛋白酶的分析。
FEBS J. 2014 Apr;281(7):1834-47. doi: 10.1111/febs.12743.
10
Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.靶向蛋白质主链的HIV蛋白酶抑制剂设计:一种对抗耐药性的有效策略。
Acc Chem Res. 2008 Jan;41(1):78-86. doi: 10.1021/ar7001232. Epub 2007 Aug 28.

引用本文的文献

1
Potential of Boronic Acid Derivatization and Activity in Agrochemical Discovery.硼酸衍生化在农用化学品发现中的潜力及活性
Molecules. 2025 Jul 18;30(14):3018. doi: 10.3390/molecules30143018.
2
Phenylboronic acid in targeted cancer therapy and diagnosis.苯硼酸在靶向癌症治疗与诊断中的应用
Theranostics. 2025 Mar 3;15(9):3733-3748. doi: 10.7150/thno.104558. eCollection 2025.
3
Boron in wound healing: a comprehensive investigation of its diverse mechanisms.硼在伤口愈合中的作用:对其多种机制的全面研究
Front Bioeng Biotechnol. 2024 Oct 30;12:1475584. doi: 10.3389/fbioe.2024.1475584. eCollection 2024.
4
Comprehending the Structure, Dynamics, and Mechanism of Action of Drug-Resistant HIV Protease.理解耐药性HIV蛋白酶的结构、动力学及作用机制。
ACS Omega. 2023 Mar 7;8(11):9748-9763. doi: 10.1021/acsomega.2c08279. eCollection 2023 Mar 21.
5
Inhibition of HIV-1 Protease by a Boronic Acid with High Oxidative Stability.具有高氧化稳定性的硼酸对HIV-1蛋白酶的抑制作用。
ACS Med Chem Lett. 2023 Jan 25;14(2):171-175. doi: 10.1021/acsmedchemlett.2c00464. eCollection 2023 Feb 9.
6
Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2' amide-derivatives: Synthesis, biological evaluation and structural studies.评估包含 P2' 酰胺衍生物的达鲁那韦衍生 HIV-1 蛋白酶抑制剂:合成、生物学评价和结构研究。
Bioorg Med Chem Lett. 2023 Mar 1;83:129168. doi: 10.1016/j.bmcl.2023.129168. Epub 2023 Feb 3.
7
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.鉴定含硼酸酯的二芳基嘧啶衍生物作为新型 HIV-1 非核苷逆转录酶抑制剂。
Molecules. 2022 Nov 3;27(21):7538. doi: 10.3390/molecules27217538.
8
Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators.新型磺胺苯甲酰胺衍生物作为 HBV 衣壳组装调节剂的设计、合成与生物评价。
Bioorg Chem. 2022 Dec;129:106192. doi: 10.1016/j.bioorg.2022.106192. Epub 2022 Oct 13.
9
Beyond darunavir: recent development of next generation HIV-1 protease inhibitors to combat drug resistance.超越达芦那韦:新一代 HIV-1 蛋白酶抑制剂抵抗耐药性的最新进展。
Chem Commun (Camb). 2022 Oct 20;58(84):11762-11782. doi: 10.1039/d2cc04541a.
10
Discovery of potent benzoxaborole inhibitors against SARS-CoV-2 main and dengue virus proteases.发现强效苯并硼氧杂环戊烷抑制剂对 SARS-CoV-2 主蛋白酶和登革热病毒蛋白酶的抑制作用。
Eur J Med Chem. 2022 Oct 5;240:114585. doi: 10.1016/j.ejmech.2022.114585. Epub 2022 Jul 11.

本文引用的文献

1
Molecular Mechanism of Aniline Induced Spleen Toxicity and Neuron Toxicity in Experimental Rat Exposure: A Review.苯胺致实验性大鼠脾毒性和神经毒性的分子机制研究进展。
Curr Neuropharmacol. 2019;17(3):201-213. doi: 10.2174/1570159X16666180803164238.
2
Nature of Intramolecular Resonance Assisted Hydrogen Bonding in Malonaldehyde and Its Saturated Analogue.丙二醛及其饱和类似物中分子内共振辅助氢键的本质
J Phys Chem A. 2018 Feb 15;122(6):1813-1820. doi: 10.1021/acs.jpca.7b12635. Epub 2018 Feb 2.
3
Crisaborole: A new and effective nonsteroidal topical drug for atopic dermatitis.克立硼罗:一种用于特应性皮炎的新型有效非甾体外用药物。
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12533. Epub 2017 Aug 23.
4
The versatility of boron in biological target engagement.硼在生物靶标结合中的多功能性。
Nat Chem. 2017 Jul 25;9(8):731-742. doi: 10.1038/nchem.2814.
5
Design and Development of Highly Potent HIV-1 Protease Inhibitors with a Crown-Like Oxotricyclic Core as the P2-Ligand To Combat Multidrug-Resistant HIV Variants.以冠状氧三环核心作为P2配体设计和开发高效HIV-1蛋白酶抑制剂以对抗多药耐药HIV变体
J Med Chem. 2017 May 25;60(10):4267-4278. doi: 10.1021/acs.jmedchem.7b00172. Epub 2017 Apr 18.
6
Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma.恩莱瑞(伊沙佐米):首个获批用于治疗复发或难治性多发性骨髓瘤患者的口服蛋白酶体抑制剂。
Am Health Drug Benefits. 2016 Mar;9(Spec Feature):102-5.
7
Fluorogenic Assay for Inhibitors of HIV-1 Protease with Sub-picomolar Affinity.用于检测具有亚皮摩尔亲和力的HIV-1蛋白酶抑制剂的荧光测定法。
Sci Rep. 2015 Aug 11;5:11286. doi: 10.1038/srep11286.
8
Structures of darunavir-resistant HIV-1 protease mutant reveal atypical binding of darunavir to wide open flaps.达芦那韦耐药 HIV-1 蛋白酶突变体的结构揭示了达芦那韦与广泛张开的瓣叶之间非典型的结合方式。
ACS Chem Biol. 2014 Jun 20;9(6):1351-8. doi: 10.1021/cb4008875. Epub 2014 Apr 28.
9
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.基于底物包膜设计的强效HIV-1蛋白酶抑制剂以避免耐药性。
Chem Biol. 2013 Sep 19;20(9):1116-24. doi: 10.1016/j.chembiol.2013.07.014. Epub 2013 Sep 5.
10
P2' benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety.P2' 苯羧酸部分与细胞摄取减少相关:含 P2 双四氢呋喃部分的新型非肽类 HIV-1 蛋白酶抑制剂的评估。
Antimicrob Agents Chemother. 2013 Oct;57(10):4920-7. doi: 10.1128/AAC.00868-13. Epub 2013 Jul 22.

硼酸盐对 HIV-1 蛋白酶的亚皮摩尔抑制作用。

Sub-picomolar Inhibition of HIV-1 Protease with a Boronic Acid.

机构信息

Department of Chemistry , Massachusetts Institute of Technology , Cambridge , Massachusetts 02139 , United States.

出版信息

J Am Chem Soc. 2018 Oct 31;140(43):14015-14018. doi: 10.1021/jacs.8b07366. Epub 2018 Oct 22.

DOI:10.1021/jacs.8b07366
PMID:30346745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6249028/
Abstract

Boronic acids have been typecast as moieties for covalent complexation and are employed only rarely as agents for non-covalent recognition. By exploiting the profuse ability of a boronic acid group to form hydrogen bonds, we have developed an inhibitor of HIV-1 protease with extraordinary affinity. Specifically, we find that replacing an aniline moiety in darunavir with a phenylboronic acid leads to 20-fold greater affinity for the protease. X-ray crystallography demonstrates that the boronic acid group participates in three hydrogen bonds, more than the amino group of darunavir or any other analog. Importantly, the boronic acid maintains its hydrogen bonds and its affinity for the drug-resistant D30N variant of HIV-1 protease. The BOH···OC hydrogen bonds between the boronic acid hydroxy group and Asp30 (or Asn30) of the protease are short ( r = 2.2 Å), and density functional theory analysis reveals a high degree of covalency. These data highlight the utility of boronic acids as versatile functional groups in the design of small-molecule ligands.

摘要

硼酸已被定型为共价络合的部分,并且很少作为非共价识别的试剂使用。通过利用硼酸基团形成氢键的丰富能力,我们开发出了一种具有非凡亲和力的 HIV-1 蛋白酶抑制剂。具体来说,我们发现用苯硼酸取代达鲁那韦中的苯胺部分会导致对蛋白酶的亲和力增加 20 倍。X 射线晶体学表明,硼酸基团参与了三个氢键,超过了达鲁那韦的氨基或任何其他类似物。重要的是,硼酸保持其氢键和对 HIV-1 蛋白酶耐药 D30N 变体的亲和力。硼酸羟基与蛋白酶的 Asp30(或 Asn30)之间的 BOH···OC 氢键较短(r = 2.2 Å),密度泛函理论分析显示出高度的共价性。这些数据突出了硼酸作为小分子配体设计中多功能官能团的实用性。